Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155479 | SCV000205172 | benign | not specified | 2013-02-21 | criteria provided, single submitter | clinical testing | *9G>A in exon 14 of CSF2RA: This variant is not expected to have clinical signif icance because it has been identified in 27.2% (1198/4406) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs141486727). |
Institute of Human Genetics, |
RCV001262878 | SCV001440912 | benign | Surfactant metabolism dysfunction, pulmonary, 4 | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001618312 | SCV001842894 | benign | not provided | 2019-01-13 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001618312 | SCV005277565 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003917531 | SCV004736117 | benign | CSF2RA-related disorder | 2019-06-13 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |